Amlodipine for Hypertension

"As this is a Phase 4 trial and thus widely approved, the safety of Amlodipine registers at 3 on our team's scale."

"Affirmative. Clinicaltrial.gov's records demonstrate that this scientific experiment is actively searching for participants, with recruitment beginning on April 11th 2021 and being updated most recently on September 26th 2022. This initiative requires 132 individuals to be sourced from one medical facility."

"Presently, Amlodipine is being studied in 39 distinct trials across 194 cities and 24 nations. This research first began with a Phase 2 clinical trial sponsored by Encysive Pharmaceuticals back in 2007 which included 27 participants. Since then, 389 studies have been carried out on the topic."

"Amlodipine is conventionally prescribed to halt premature labour, but also has a role in treating pulmonary hypertension and anal fissures. Additionally, it can be employed if dietary changes fail to make an impact on certain conditions."

"Indeed, the information on clinicaltrials.gov suggests that enrollment is now open for this medical trial. It was first publicized in April 2021 and has been recently updated on September 26th 2022. A total of 132 individuals are expected to take part from a single location."

"Presently, Amlodipine is being test in 392 clinical trials with 9 of those studies at the Phase 3 level. Of these locations, a notable amount are based in Boston, Massachusetts while the rest are dispersed across different parts of the globe."